Keywords: 5mc; 5-methyl cytosine; 5hmc; 5-hydroxymethylcytosine; ALL; Acute Lymphoblastic Leukemia; ASE; Allele-specific gene expression; B-All; B-cell precursor lineage ALL; CpG; CG dinucleotide; CGI; CpG island; CIMP; CpG island methylator phenotype; DMCs; Differ
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ABC; ATP-binding cassette transporters; ADSL; Adenylosuccinate Lyase; ALL; Acute Lymphoblastic Leukemia; ARID5B; AT-rich interaction domain 5B; B-ALL; B-Cell Acute Lymphoblastic Leukemia; BCR-ABL1; Breakpoint Cluster Region-ABelson murine Leukemia viral o
Keywords: γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke
Keywords: B-ALL; ETV6-RUNX1; aCGH; Cryptic unbalanced translocation; der(6)t(X;6)
Double sword role of EZH2 in leukemia
Keywords: EZH1,2; enhancer of Zeste 1 and 2; SUZ12; suppressor of zeste 12 homolog; EED; embryonic ectoderm development; AEBP2; adipocyte enhancer-binding protein 2; RBAP46/48; retinoblastoma binding proteins 46 and 48; PRC; polycomb-repressive complex; PcG; Polyco
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All)
Keywords: B-ALL; B-acute lymphoblastic leukemia; Dex; dexamethasone; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Ribo; ribociclib; RPPA; reverse phase protein array; PI; propidium iodide; Dexamethasone (PubChem CID: 24893536); Ribociclib (Pub
Up-regulation of HO-1 promotes resistance of B-cell acute lymphocytic leukemia cells to HDAC4/5 inhibitor LMK-235 via the Smad7 pathway
Keywords: B-ALL; Apoptosis; LMK-235; HO-1; Smad7; Prognosis;
Bispecific antibodies for cancer therapy: A review
Keywords: ADCC; antibody-dependent cell-mediated cytotoxicity; AE; adverse events; ALL; acute lymphoblastic leukemia; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; B-ALL; B-cell acute lymphoblastic leukemia; BiTES; Bi-sp
Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using “MRD lite” panel
Keywords: MRD “lite”; B-ALL; CD19; CD10; CD34;
Original ArticlesInfluence of Musculoskeletal Manifestations as the Only Presenting Symptom in B-Cell Acute Lymphoblastic Leukemia
Keywords: children; symptom duration; limb pain; overall survival; ALL; Acute lymphoblastic leukemia; B-ALL; B-cell type acute lymphoblastic leukemia; HR; Hazard ratio; MRD; Minimal residual disease; NCI; National Cancer Institute; WBC; White blood cell;
Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia
Keywords: B-ALL; B acute lymphoblastic leukemia; ER; endoplasmic reticulum; UPR; unfolded protein response; ERAD; ER-associated degradation; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; HNA; 2-hydroxy-1-naphthaldehyde; PI; propidium iodide; PE
The role of G protein-coupled receptors in lymphoid malignancies
Keywords: ABC; activated B cell-like; ALL; acute lymphoblastic leukemia; ATP; adenosine triphosphate; B-ALL; B cell acute lymphoblastic leukemia; BCR; B cell receptor; BL; Burkitt lymphoma; BLR1; Burkitt lymphoma receptor 1; cAMP; cyclic adenosine monophosphate; CC
Chimeric antigen receptor T-cells for B-cell malignancies
Keywords: ALL; acute lymphoblastic leukemia; B-ALL; B-cell acute lymphoblastic leukemia; CAR-T; chimeric antigen receptor T-cell; CAR; chimeric antigen receptor; CD; cluster of differentiation; CHOP; Children's Hospital of Philadelphia; CLL; chronic lymphocytic leu
Development of CAR T cells designed to improve antitumor efficacy and safety
Keywords: 28z; CD28 + CD3ζ; 4-1BBL; 4-1BB ligand; B-ALL; B cell acute lymphatic leukemia; BBz; 4-1BB + CD3ζ; CAR; chimeric antigen receptor; CD40L; CD40 ligand; CRS; cytokine release syndrome; CTLA-4; cytotoxic T-lymphocyte associated protein 4; DCs; dendriti
Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
Keywords: AAH; atypical adenomatous hyperplasia; AK; actinic keratosis; AML; acute myelogenous leukemia; AMM; asymptomatic multiple myeloma; APC; antigen presenting cell; B-ALL; B cell acute lymphocytic leukemia; B-CLL; B cell chronic lymphocytic leukemia; BD; Bowe
Significance of CD34/CD123 expression in detection of minimal residual disease in B-ACUTE lymphoblastic leukemia in children
Keywords: CD34; CD123; B-ALL; Minimal residual disease; IL3 receptor;
Combined IKZF1 and IG markers as new tools for diagnosis and minimal residual disease assessment in Tunisian B-ALL
Keywords: IGH/IGK-Kde rearrangements; IKZF1 deletion; B-ALL; MRD; RQ-PCR; MLPA; Réarrangements IGH/IGK-Kde; Délétion IKZF1; LAL-B; MRD; RQ-PCR; MLPA;
Effects of the I682F mutation on JAK2's activity, structure and stability
Keywords: JAK; Janus kinase; JH; JAK homology; STAT5s; ignal transducer and activator of transcription 5; B-ALL; B-cell acute lymphoblastic leukemia; MPDs; myeloproliferative disorders; ALL; acute lymphoblastic leukemia; WT; Wild type; ANS; 1-anilino-8-naphthalenes
ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemia
Keywords: B-ALL; B-cell acute lymphoblastic leukemia; ATO; arsenic trioxide; ADAMA; disintegrin and metalloproteinases; RFS; relapse-free survival; EFS; event-free survival; OS; overall survival; CR; complete remission; CNS; central nervous system; ATRA; all-trans
Down Syndrome Preleukemia and Leukemia
Keywords: Down syndrome; Preleukemia; Leukemia; Myeloid leukemia of Down syndrome; B-ALL; GATA1; Transient abnormal hematopoiesis/transient myeloproliferative disorder;
Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study
Keywords: B-ALL; microarray; ETV6-RUNX1; hypodiploid; IKZF1; iAMP21
Concurrence of B-lymphoblastic leukemia and myeloproliferative neoplasm with copy neutral loss of heterozygosity at chromosome 1p harboring a MPL W515S mutation
Keywords: B-lymphoblastic leukemia/lymphoma/B-cell acute lymphoblastic leukemia; B-ALL; myeloproliferative neoplasm; copy neutral loss of heterozygosity; MPL mutation;
C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
Keywords: C-myc; B-ALL; Acute lymphoblastic leukemia; Prognosis; Protein expression; Cytogenetics; Childhood leukemia; Adult leukemia; Immunostaining; Immunohistochemistry;
Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigens
Keywords: B-ALL; B cell acute lymphoblastic leukemia; CEPH; Centre d'Etude Polymorphism Humain, CML, chronic myeloid leukemia; CTL; cytotoxic T lymphocyte; FCS; fetal calf serum; GVHD; graft-versus-host disease; GVL; graft-versus-leukemia; HS; human serum; IMDM; Is